Skip to main content

Pruritus News

Related terms: Itching, Itchy Skin

Remibrutinib Beneficial for Urticaria After H1-Antihistamine Treatment

TUESDAY, March 11, 2025 – For patients with symptomatic chronic spontaneous urticaria after treatment with second-generation H1-antihistamines, administration of the oral, highly selective Bruton's...

Gestational Exposure to NSAIDs Tied to Childhood Chronic Kidney Disease

MONDAY, Jan. 6, 2025 – Gestational exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with an increased risk for childhood chronic kidney disease (CHD), although the association...

Ditch That Itch: Early Findings Offer Hope for Skin Issues Like Rosacea

THURSDAY, Dec. 12, 2024 – It's still early science – studies in mice and in human cells – but researchers are on the trail of an effective new treatment for inflammatory skin conditions such as...

Mirum Pharmaceuticals’ Livmarli Receives FDA Approval for Treatment of Cholestatic Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis

FOSTER CITY, Calif.--(BUSINESS WIRE) March 13, 2024 – Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that the U.S. Food and Drug Administration (FDA) has approved Livmarli® ...

FDA Medwatch Alert: Piyanping Anti-Itch Lotion: Recall - Incorrect Active Ingredient

ISSUE: Lucky Mart Inc. is voluntarily recalling lots C14005, C16001 and C16002 of Piyanping Anti-Itch Lotion to the consumer level. The product was manufactured using the active pharmaceutical...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Dermatological Disorders

Related drug support groups

gabapentin, Benadryl, hydroxyzine, diphenhydramine, ondansetron, Vistaril, Atarax, cyproheptadine